(MedPage Today) — A tailored CRISPR base-editing therapy was given for the first time to an infant who was born with a rare genetic disease, with promising effects, researchers reported.
After the baby, named KJ, received a diagnosis of severe…
Source link : https://www.medpagetoday.com/genetics/generalgenetics/115600
Author :
Publish date : 2025-05-15 18:09:00
Copyright for syndicated content belongs to the linked Source.
